<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Collagen VI is an extracellular matrix protein that forms a microfilamentous network in skeletal muscles and other organs </plain></SENT>
<SENT sid="1" pm="."><plain>Inherited mutations in genes encoding collagen VI in humans cause two muscle diseases, Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> and Ullrich <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We previously generated collagen VI-deficient (Col6a1-/-) mice and showed that they have a <z:mp ids='MP_0005369'>muscle phenotype</z:mp> that strongly resembles Bethlem <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The pathophysiological defects and mechanisms leading to the myopathic disorder were not known </plain></SENT>
<SENT sid="4" pm="."><plain>Here we show that Col6a1-/- muscles have a loss of contractile strength associated with ultrastructural alterations of sarcoplasmic reticulum (SR) and mitochondria and spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>We found a latent <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction in myofibers of Col6a1-/- mice on incubation with the selective F1F(O)-ATPase inhibitor oligomycin, which caused <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> depolarization, <z:chebi fb="0" ids="29108">Ca2+</z:chebi> deregulation and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>These defects were reversible, as they could be normalized by plating Col6a1-/- myofibers on collagen VI or by addition of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA), the inhibitor of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore (<z:chebi fb="0" ids="52242">PTP</z:chebi>) </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment of Col6a1-/- mice with CsA rescued the muscle ultrastructural defects and markedly decreased the number of apoptotic nuclei in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>These findings indicate that collagen VI <z:hpo ids='HP_0003198'>myopathies</z:hpo> have an unexpected <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathogenesis that could be exploited for therapeutic intervention </plain></SENT>
</text></document>